Abstract:OBJECTIVE To study the effect and the underlying molecular mechanisms of a novel histone deacetylases(HDAC) inhibitor named DWP0016 in lung carcinoma A549 cells and xenografts.METHODS ① In vitro: A549 cells were treated with DWP0016 0.625-10 μmol·L-1 for 48 h before cell viability was detected by MTT assay.The effect of DWP0016 on mRNA level of phosphatase and tensin homolog deleted on chromosome 10(PTEN) was detected by real-time PCR.The protein expression of total H3,acetylated-H3(Ac-H3),p21,PTEN,total-Akt and phosphorylated-Akt(p-Akt) was detected by Western blotting.② In vivo: Lewis lung cancer animal models were constructed by injecting the axillae with 0.2 ml tumor suspension.After 7 d,the xenografts groups were ip given DWP0016 12.5,25 and 50 mg·kg-1 and positive drug vorinostat(SAHA) 50 mg·kg-1,once daily,for 8 d.After treatment,the animals were sacrificed to get the tumors.The tumor specimens were weighed and the tumor growth inhibition was calculated.The expression of Ac-H3 and PTEN in the specimen was detected by immunohistochemical assay.RESULTS ① In vitro: MTT results showed that IC50 of DWP0016 was 2.51 μmol·L-1 and IC50 of SAHA was 6.03 μmol·L-1.Compared with normal control,DWP0016 significantly up-regulated the protein expression of Ac-H3 and p21 at the concentration of 2.5 μmol·L-1(P< 0.05).DWP0016 promoted the mRNA level and protein expression of PTEN while decreasing the expression of p-Akt concentration-dependently(P<0.05).② In vivo: compared with model group,the mean mass of the specimens from DWP0016 12.5 mg·kg-1 significantly decreased(P<0.05) with a 42.0% tumor growth inhibition.The tumor growth inhibition in DWP0016 50 mg·kg-1 group was higher than in SAHA 50 mg·kg-1 group(P<0.05).Compared with the model group,the expression of Ac-H3 and PTEN in tumor specimens was up-regulated by DWP0016.CONCLUSION DWP0016 effectively inhibits the proliferation in A549 cells and the tumor growth in xenografts.The molecular mechanisms are associated with the induction of Ac-H3,the activation of p21,PTEN and down-regulation of p-Akt.DWP0016 is a potent compound to be developed as an anti-tumor agent for clinic application in the future.

Hdac Inhibitor Dwp0016 Suppresses Mir-22 to Induce Growth Inhibition and Apoptosis Via P53-Independent Pten Activation in Neuroblastoma Sh-Sy5y Cells

HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells.

Antitumor activity of histone deacetylases inhibitor,DWP0016,in lung carcinoma A549 cells and xenograft mouse model

Targeting Histone Deacetylases (hdacs) and Wee1 for Treating High-Risk Neuroblastoma.

Smoothened-Independent Activation of Hedgehog Signaling by Rearranged During Transfection Promotes Neuroblastoma Cell Proliferation and Tumor Growth

The Dual HDAC and PI3K Inhibitor, CUDC‑907, Inhibits Tumor Growth and Stem‑like Properties by Suppressing PTX3 in Neuroblastoma.

BI-D1870 Induces Mitotic Dysfunction and Apoptosis in Neuroblastoma by Regulating the PI3K-Akt-mTORC1 Signal Axis

10-Hydroxycamptothecin induces apoptosis in human neuroblastoma SMS-KCNR cells through p53, cytochrome c and caspase 3 pathways.

Research on the Block of Cell Cycle and Apoptosis Induction on Glioma Cell Line U251 of a Novel HDAC Inhibitor Named DWP0016

Activation of the p53 signaling pathway by piRNA-MW557525 overexpression induces a G0/G1 phase arrest thus inhibiting neuroblastoma growth

Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer.

The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma

A novel histone deacetylase inhibitor MPT0L184 dysregulates cell-cycle checkpoints and initiates unscheduled mitotic signaling

Discovery of a 2,6-diarylpyridine-based hydroxamic acid derivative as novel histone deacetylase 8 and tubulin dual inhibitor for the treatment of neuroblastoma

HDAC6 Regulates Neuroblastoma Cell Migration and May Play a Role in the Invasion Process.

A Novel Imidazopyridine Derivative, HS-106, Induces Apoptosis of Breast Cancer Cells and Represses Angiogenesis by Targeting the PI3K/mTOR Pathway.

Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma

PXD101 Inhibits Malignant Progression and Radioresistance of Glioblastoma by Upregulating GADD45A

AG1031 Induces Apoptosis Through Suppressing SIRT1/p53 Pathway in Human Neuroblastoma Cells

Abstract 2785: Discovery of a Novel HDM2 Inhibitor with Potent in Vivo Anti-Tumor Activity